Unknown PHASE1 INTERVENTIONAL NCT00490594

SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction

A Multi-Center Open Study to Evaluate the SeriACL™ Device for Primary Anterior Cruciate Ligament Repair

Sponsor: Serica Technologies, Inc.

Conditions Anterior Cruciate Ligament Knee Injuries

Interventions ACL Reconstruction (SeriACL™ Device)

Updated 5 times since 2017 Last updated: Oct 17, 2008 Started: Jun 30, 2007 Primary completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Anterior Cruciate Ligament and Knee Injuries, this trial is ongoing. The trial is conducted by Serica Technologies, Inc. and has accumulated 5 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Serica Technologies, Inc.

Data source: Serica Technologies, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Heidelberg, Germany
• Oslo, Norway